Author

Gustavo Palacios

Icahn School of Medicine at Mount SinaiPrimary ORCID profile (0009-0001-2483-3774 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Gustavo PalaciosiD1 paper · St. Jude Children's Research Hospital

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Adolfo García‐SastreiD· 1 shared Arturo LevicániD· 1 shared Farah El-Ayache· 1 shared Gabriel LaghlaliiD· 1 shared Gagandeep SinghiD· 1 shared Jorge LévicaniD· 1 shared Lauren A. ChangiD· 1 shared Leonie Gruneberg· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Adolfo García‐SastreORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Evaluation of new adjuvants in enhancing the immune response to a candidate of Severe Fever with Thrombocytopenia Syndrome Virus vaccine.

Jorge Lévican, N.M. Ferressini Gerpe, Seok‐Chan Park, Moataz Noureddine, Farah El-Ayache, Vivian Yan, Leonie Gruneberg, M Prellberg, Lauren A. Chang, Gabriel Laghlali, Gagandeep Singh, Pamela T. Wong, Arturo Levicán, Gustavo Palacios, Adolfo García‐Sastre, Michael Schotsaert

This study evaluates adjuvants for a SFTSV vaccine, finding that Addavax and SDI enhance neutralizing antibodies and immune memory, with NP as a key target.

bioRxiv · Sep 12, 2026 · PreprintMicrobiology